Author

D. Siegrist

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Pizzorno· 1 shared B. Boda· 1 shared B. Padey· 1 shared H. R. Jonsdottir· 1 shared K. Samby· 1 shared M. Bouveret· 1 shared M. Rosa-Calatrava· 1 shared O. Engler· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Pizzorno

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro

H. R. Jonsdottir, D. Siegrist, T. Julien, B. Padey, M. Bouveret, O. Terrier, A. Pizzorno, S. Huang, K. Samby, T. Wells, B. Boda, M. Rosa-Calatrava, O. Engler, S. Constant

The paper evaluates antiviral effects of 95 single compounds and 30 combinations, showing that molnupiravir with other drugs inhibits SARS-CoV-2 replication in human nasal epithelium in vitro.

bioRxiv · Jan 10, 2022Microbiology